Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer

被引:0
|
作者
Noel Pabalan
Ofelia Francisco-Pabalan
Lillian Sung
Hamdi Jarjanazi
Hilmi Ozcelik
机构
[1] Saint Louis University,College of Natural Sciences
[2] University Health Network,Analytical Genetics Technology Centre, Princess Margaret Hospital
[3] Hospital for Sick Children,Division of Hematology/Oncology
[4] Ontario Ministry of the Environment,Environmental Monitoring and Reporting Branch
[5] Mount Sinai Hospital,Fred A. Litwin Centre for Cancer Genetics, Samuel Lunenfeld Research Institute
来源
Breast Cancer Research and Treatment | 2010年 / 124卷
关键词
Breast cancer; ERCC2; XPD; Asp312Asn; Lys751Gln; Adducts;
D O I
暂无
中图分类号
学科分类号
摘要
The excision repair cross-complementing group 2 gene (ERCC2) plays a key role in DNA repair. Several polymorphisms in the ERCC2 gene have been described, including the commonly occurring Lys751Gln and Asp312Asn polymorphisms. Studies investigating the association of these polymorphisms with breast cancer risk produced controversial results. To evaluate these associations presented in diverse populations, we have conducted a meta-analysis based on 40 studies from 33 publications in PubMed which included analyses of Lys751Gln (14,545 cases, 15,352 controls) and Asp312Asn polymorphisms (16,254 cases, 14,006 controls). Overall findings of both polymorphisms have implicated null effects (OR = 1.01–1.03) when the analyses were limited to the statistically powerful (≥80%) studies. Although modestly increased statistically significant breast cancer risk was detected in the underpowered studies (≤80%), removal of outliers resulted in null associations. Ethnic stratification showed non-significant and relatively null associations for both polymorphisms with breast cancer risk for the overall Caucasians as well as North American and the European sub-populations. Although statistically increased and decreased risks were observed for the homogenous populations of African-Americans (Lys751Gln, OR 1.25, 95% CI 1.03–1.53, P = 0.03) and Asians (Asp312Asn, ORs: 0.53–0.55, P values: 0.02–0.03), respectively, this may be the result of small sample size. Analyses of the homogeneous adduct studies, with relatively large sample size, exhibited increased risk for Lys751Gln (OR 1.20, 95% CI (1.02–1.41), P = 0.03) and Asp312Asn (OR 1.17 95% CI 1.02–1.34, P = 0.03) under the dominant genetic model. In conclusion, our results suggest null associations of both polymorphisms in the overall and the Caucasian subgroups, although some effects can be suggested for relatively smaller minority studies. Increased risk effect was more visible when the adduct studies are considered, suggesting the role of these polymorphisms in the presence of exposure to DNA damaging agents.
引用
收藏
页码:531 / 541
页数:10
相关论文
共 50 条
  • [41] XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects
    Qiu, Li-Xin
    Yao, Lei
    Zhang, Jian
    Zhu, Xiao-Dong
    Zhao, Xin-Min
    Xue, Kai
    Mao, Chen
    Chen, Bo
    Zhan, Ping
    Yuan, Hui
    Hu, Xi-Chun
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (01) : 229 - 235
  • [42] Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis
    Yuan, H.
    Niu, Y. M.
    Wang, R. X.
    Li, H. Z.
    Chen, N.
    GENETICS AND MOLECULAR RESEARCH, 2011, 10 (04) : 3356 - 3364
  • [43] XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case–control studies
    Da-Peng Ding
    Wen-Li Ma
    Xiao-Feng He
    Ying Zhang
    Molecular Biology Reports, 2012, 39 : 2533 - 2540
  • [44] Lack of association between the XPD Lys751Gln polymorphism and colorectal cancer risk: a meta-analysis
    Zhang, Tao
    Zhang, Dong-ming
    Zhao, Da
    Hou, Xiao-ming
    Ma, Shou-cheng
    Liu, Xiao-jun
    ONCOTARGETS AND THERAPY, 2014, 7 : 1255 - 1260
  • [45] Association between ERCC2 Lys751Gln polymorphism and the risk of pancreatic cancer, especially among Asians: evidence from a meta-analysis
    Wu, Yang
    Lu, Zi-Peng
    Zhang, Jing-Jing
    Liu, Dong-Fang
    Shi, Guo-Dong
    Zhang, Chun
    Qin, Zhi-Qiang
    Zhang, Jian-Zhong
    He, Yuan
    Wu, Peng-Fei
    Miao, Yi
    Jiang, Kui-Rong
    ONCOTARGET, 2017, 8 (30) : 50124 - 50132
  • [46] XPD Lys751Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis
    Cui, Jing
    Li, Dalu
    Shen, Liang
    Zhang, Wenmei
    Xu, Xin
    TUMOR BIOLOGY, 2014, 35 (07) : 6335 - 6341
  • [47] Association Between ERCC2 Lys751Gln Polymorphism and Lung Cancer Risk: A Meta-Analysis Involving 23,370 Subjects
    Tan, Xiang
    Xian, Lei
    Chen, Xinyu
    Shi, Lijun
    Wang, Yongyong
    Guo, Jianji
    Liang, Guanbiao
    Zhao, Zhenqing
    Chen, Mingwu
    TWIN RESEARCH AND HUMAN GENETICS, 2014, 17 (02) : 99 - 107
  • [48] The relationship between XPD Asp312Asn Polymorphism and esophageal cancer in Chinese population: a meta-analysis
    Yu, Dahui
    Wu, Daoli
    Yuan, Chong
    Zhang, Hedan
    Chu, Wenyan
    FOOD SCIENCE AND TECHNOLOGY, 2022, 42
  • [49] Lys751Gln polymorphism in ERCC2 gene is associated with lung cancer susceptibility in the Chinese population
    Liang, Geyu
    Pu, Yuepu
    Yin, Lihong
    PROGRESS IN NATURAL SCIENCE-MATERIALS INTERNATIONAL, 2007, 17 (07) : 872 - 876
  • [50] Lys751Gln polymorphism in ERCC2 gene is associated with lung cancer susceptibility in the Chinese population
    Liang Geyu Pu Yuepu Yin Lihong (School of Public Health
    ProgressinNaturalScience, 2007, (07) : 872 - 876